Literature DB >> 2328210

Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukaemia (t-ANLL).

G Sozzi1, M Miozzo, A Orazi, C Calderone, M Castellano, S Viviani, A Santoro, M A Pierotti, G Della Porta.   

Abstract

A cytogenetic study was performed in 27 patients suspected of t-MDS or t-ANLL. In 12 patients the diagnosis of t-MDS or t-ANLL was confirmed by morphological, cytochemical and immunophenotypical analysis. The cases were classified as RA (one), RAEB (four), CMML (two), ANLL (five). They had received chemotherapy and/or RT for Hodgkin's disease (eight cases), solid tumours (three cases) and multiple myeloma (one case). Clonal chromosome abnormalities were found in bone marrow or peripheral blood cells in all the 12 cases. Five patients had a clonal abnormality of chromosome no. 5 (monosomy, deletions, translocation and inversion of 5q). The critical region on chromosome no. 5 comprised bands q12-q34. Monosomy and deletion of chromosome 7q was observed in the other two patients. In the six remaining patients various karyotypic patterns were observed including a t(4;11) (q21;q23) in one case, monosomies (four cases) and trisomies (one case) of different chromosomes. In the other 15 cases, the presence of a normal karyotype together with the morphological and immunophenotypical characterisation was consistent with a diagnosis of non-neoplastic specimens.

Entities:  

Mesh:

Year:  1990        PMID: 2328210      PMCID: PMC1971308          DOI: 10.1038/bjc.1990.93

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  The karyotype in secondary hematologic disorders after treatment for Hodgkin's disease. A study of 19 patients.

Authors:  A Iurlo; C Mecucci; A Van Orshoven; J L Michaux; M Boogaerts; H Van den Berghe
Journal:  Cancer Genet Cytogenet       Date:  1988-12

2.  Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease.

Authors:  J Pedersen-Bjergaard; S O Larsen
Journal:  N Engl J Med       Date:  1982-10-14       Impact factor: 91.245

3.  Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphoma.

Authors:  G A Gomez; K K Aggarwal; T Han
Journal:  Cancer       Date:  1982-12-01       Impact factor: 6.860

4.  Acute myeloblastic leukemia following treatment for non-hematopoietic cancers: report of 19 cases and review of the literature.

Authors:  M H Zarrabi; F Rosner
Journal:  Am J Hematol       Date:  1979       Impact factor: 10.047

5.  New chromosome techniques in the study of human neoplasia.

Authors:  J J Yunis
Journal:  Hum Pathol       Date:  1981-06       Impact factor: 3.466

6.  Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease.

Authors:  J D Rowley; H M Golomb; J W Vardiman
Journal:  Blood       Date:  1981-10       Impact factor: 22.113

7.  Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients.

Authors:  J Pedersen-Bjergaard; P Philip; N T Pedersen; K Hou-Jensen; A Svejgaard; G Jensen; N I Nissen
Journal:  Cancer       Date:  1984-08-01       Impact factor: 6.860

8.  Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders.

Authors:  M M Le Beau; C A Westbrook; M O Diaz; R A Larson; J D Rowley; J C Gasson; D W Golde; C J Sherr
Journal:  Science       Date:  1986-02-28       Impact factor: 47.728

9.  Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.

Authors:  M M Le Beau; K S Albain; R A Larson; J W Vardiman; E M Davis; R R Blough; H M Golomb; J D Rowley
Journal:  J Clin Oncol       Date:  1986-03       Impact factor: 44.544

10.  Therapy-related preleukemic syndrome.

Authors:  R L Anderson; G C Bagby; K Richert-Boe; R E Magenis; R D Koler
Journal:  Cancer       Date:  1981-04-01       Impact factor: 6.860

View more
  1 in total

1.  Inhibition of human DNA topoisomerase II by hydroquinone and p-benzoquinone, reactive metabolites of benzene.

Authors:  A M Hutt; G F Kalf
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.